Multiple Myeloma — Trials

Multiple Myeloma — Trials · CancerIndex

Clinical trials

Registered studies

3,384 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 814
Recruiting: 414
Ph III recruiting: 54
Growth YoY: +13.3%
Industry share: 29%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34%
Trials / 1,000 deaths: 70.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (536)

clinicaltrialsPublishedShowing 1–50 of 110 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03225417	Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.	unknown	Phase 1 / Phase 2	142	Fundación Pública Andaluza para la gestión de la Investigación en SevillaOTHER	1	Aug 30, 2024	clinicaltrials
NCT05422027	Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma	unknown	Phase 1 / Phase 2	42	Xia ZhongjunOTHER	1	Jun 17, 2024	clinicaltrials